IQVIA (IQV) Stock Price & AI Analysis

$148.99
-$4.31
(2.81%)
Life Sciences Tools & Services

NYSE USA

May 12, 8:49 PM EDT
  • Market Cap.
    25.78B
  • Volume
    1.67M
  • Avg. Volume
    1.86M
  • Target Price
    $193.05
  • 52W Range
    135.97 - 252.88
  • RSI (14)
    43.03
  • Beta
    1.35
  • PEG Ratio
    2.26
  • SMA 20
    -0.2800%
  • SMA 50
    -10.35%
  • SMA 200
    -27.26%
  • Insider Owner
    0.86%
  • Insider Trans
    0.09%
  • Institution Owner
    94.6%
  • Institution Trans
    0.93%
  • Short Interest
    2.81%
  • EPS next Y
    10.22

IQVIA Company Profile

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm’s life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm’s life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

IQVIA | Latest news

IQVIA (NYSE:IQV) Beats Q1 Sales Targets, Full-Year Sales Guidance is Optimistic

Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results topping the market’s revenue...

StockStory - 7 days ago

Schonfeld Strategic Advisors LLC Lowers Stock Holdings in IQVIA Holdings Inc....

Schonfeld Strategic Advisors LLC decreased its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 95.8% during the fourth quarter, according to the company in its most recent ...

ETF DAILY NEWS - 20 hours ago

IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates

IQVIA (IQV) delivered earnings and revenue surprises of 2.66% and 1.55%, respectively, for the...

Zacks - 7 days ago

IQVIA Earnings & Revenues Beat Estimates in Q1, Increase Y/Y

IQVIA Holdings Analytics Inc. IQV has reported impressive first-quarter 2025 results, wherein...

Zacks - 6 days ago

IQVIA (IQV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter...

Zacks - 6 days ago

IQVIA Holdings (NYSE:IQV) Reports US$3,829 Million Sales Q1 2025; Raises...

IQVIA Holdings (NYSE:IQV) recently announced its first-quarter earnings report, revealing a modest...

Simply Wall St - 6 days ago

IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth...

IQVIA Holdings Inc (IQV) reports robust Q1 results with significant growth in Technology and...

GuruFocuscom - 6 days ago

IQVIA Holdings Inc. (NYSE:IQV) Given Average Rating of “Moderate Buy” by...

IQVIA Holdings Inc. (NYSE:IQV – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-four brokerages that are presently covering the stock, Marketbeat.com ...

ETF DAILY NEWS - 7 days ago

IQVIA: Q1 Earnings Snapshot - WTOP News

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — IQVIA Holdings Inc. (IQV) on Tuesday reported first-quarter profit of $249 million. On a per-share basis, the Durham, North Carolina-based company said it had…

WTOP Washington - 7 days ago

Stocks Fall On Trade Concerns, Oil And Gold Rally: What's Driving Markets...

Wall Street edged lower by midday Tuesday as uncertainty surrounding trade policies lingered, with...

Benzinga - 6 days ago